Omadacycline
| Recommendation | No dose adjustment appears necessary |
|---|---|
| Comments | Based on two post hoc analyses of clinical trial data (Pharmacotherapy 2023;43:226). |
| Recommendation | No dose adjustment appears necessary |
|---|---|
| Comments | Based on two post hoc analyses of clinical trial data (Pharmacotherapy 2023;43:226). |